|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||104.39 - 104.39|
|52-week range||104.39 - 104.39|
|Beta (5Y monthly)||0.80|
|PE ratio (TTM)||30.77|
|Earnings date||29 Jul 2021 - 02 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Eli Lilly CEO David Ricks joins 'Influencers with Andy Serwer' to discuss the FDA's approval of Biogen's new Alzheimer’s drug.
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
CEO Rick Gonzalez has done a decent job of delivering relatively good performance at AbbVie Inc. ( NYSE:ABBV...